![]() |
市场调查报告书
商品编码
1559470
核磁共振 (NMR) 波谱仪 - 市场回顾、竞争格局、市场预测 (2030)Nuclear Magnetic Resonance (NMR) Spectrometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
估计2024年至2030年预测期内,全球核磁共振 (NMR) 波谱仪市场规模将以 5.21%的年复合成长率成长。由于更高的磁场强度和低温冷却探针等进步,提高了详细分子研究的灵敏度和分辨率,预计市场将会成长。自动化高通量系统提高了资料收集效率并满足快速分析的需求。在製药和生物技术领域,核磁共振波谱仪透过提供精确的结构解析、化合物筛选、代谢物分析等,在药物发现和开发中发挥非常重要的作用。生物製剂的重要性日益增加,凸显了对核磁共振等先进技术的需求。此外,代谢组学和代谢分析在个人化医疗和生物标记发现中的越来越多的使用进一步推动了2024-2030年预测期内的市场成长。
核磁共振 (NMR) 波谱仪市场动态
在药物发现和开发中,核磁共振波谱对于确定新化合物的结构和筛选潜在候选药物的大型库非常重要。它透过提供详细的分子成分资讯来检测杂质并确保批次一致性,在品质控制和保证中发挥关键作用。此外,监管合规性进一步推动了对 NMR 的需求,因为它提供了药物审批所需的全面分子资料。核磁共振技术的进步,包括提高灵敏度和解析度、自动化和高通量系统,日益增加其对製药应用的吸引力。
此外,生物製剂和复杂分子的增加也增加了对 NMR 等先进分析技术的需求。协作研究和外包趋势促进市场成长,製药公司依赖专门的NMR 设施来满足其分析需求。总体而言,药品复杂性的增加、对详细分子分析的需求以及严格的监管要求是推动核磁共振波谱仪市场扩张的主要因素。
推动核磁共振 (NMR) 波谱仪市场扩张的另一个因素是临床试验活动的增加。例如,2024年5月,Arvinas, Inc. 和Pfizer Inc. 宣布了评估 vepdegestrant 的1b 期联合队列的最新临床资料,一种研究性口服蛋白水解靶向嵌合体 (PROTAC (R) ) 雌激素受体 (ER) 降解剂,与 palbociclib (IBRANCE (R) ) 联合使用。
因此,製药公司依靠 NMR 在这些阶段进行精确的结构阐明、化合物筛选和代谢物分析。随着越来越多的药物进行临床试验,对核磁共振波谱仪支持潜在候选药物的表征和验证的需求将会增加。核磁共振波谱仪需求的预期激增预计将推动2024-2030年预测期内核磁共振波谱仪市场的整体成长。
然而,缺乏训练有素的人员来有效操作核磁共振设备以及核磁共振的高成本可能会限制整体市场的成长。
核磁共振 (NMR) 波谱仪市场区隔分析
在整个核磁共振 (NMR) 波谱仪市场的产品类型部分,仪器类别预计将在2023年占据最大占有率。仪器核磁共振的巨大市场占有率是由其众多优势推动的。仪器式核磁共振波谱仪具有无数的优点,使其成为各领域不可或缺的分析技术。首先,它允许无损分析,保留样品的完整性以供后续实验和进一步分析。 NMR 产生详细的结构讯息,揭示溶液中分子的化学成分、组织和空间排列。
此外,浓度和化学计量的精确测定有利于定量分析。其多功能性扩展到多种样品类型,包括有机小分子、蛋白质、核酸、聚合物和复杂混合物,并允许分析各种状态的样品,包括溶液、固体和气体。此外,核磁共振波谱透过弛豫测量和扩散核磁共振等技术,可以深入了解分子动力学,包括结构变化、运动和相互作用。现代仪器具有灵敏度和选择性,可以检测低浓度的化合物,并为分子内的不同核提供不同的讯号。
本报告研究和分析了全球核磁共振 (NMR) 波谱仪市场,提供了每个地区的市场规模和预测、过去三年的产品/技术发展以及每个细分市场的业绩和前景等讯息。
Nuclear Magnetic Resonance (NMR) Spectroscopy Market By Product Type (Instruments, Accessories), By Type (Low-Field NMR Spectroscopy, High-Field NMR Spectroscopy), End-User (Academic, Pharmaceutical & Biotech Companies, Agriculture & Food, And Others) And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to demand for drug discovery and drug administration in pharmaceutical companies among others
The Nuclear Magnetic Resonance (NMR) Spectroscopy market is estimated to grow at a CAGR of 5.21% during the forecast period from 2024 to 2030. The NMR Spectroscopy market is set for growth due to advancements like higher magnetic field strengths and cryogenically cooled probes, which improve sensitivity and resolution for detailed molecular studies. Automated, high-throughput systems enhance data collection efficiency, meeting the need for rapid analysis. In the pharmaceutical and biotechnology sectors, NMR spectroscopy plays a pivotal role in drug discovery and development by providing precise structural elucidation, compound screening, and metabolite analysis. The increasing importance of biologics highlights the need for sophisticated techniques like NMR. Additionally, expanding applications in metabolomics and personalized medicine for metabolite profiling and biomarker discovery further drives the market growth during the forecast period of 2024 to 2030.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Dynamics:
In drug discovery and development, NMR spectroscopy is essential for determining the structure of new compounds and screening large libraries of potential drug candidates. It plays a critical role in quality control and assurance by providing detailed molecular composition information to detect impurities and ensure batch consistency. Additionally, regulatory compliance further drives the demand for NMR as it provides comprehensive molecular data required for drug approval. Advancements in NMR technology, such as improved sensitivity and resolution, along with automation and high-throughput systems, make it increasingly attractive for pharmaceutical applications.
Additionally, the rise of biologics and complex molecules also boosts the need for advanced analytical techniques like NMR. Collaborative research and outsourcing trends contribute to market growth, the pharmaceutical companies rely on specialized NMR facilities for their analytical needs. Overall, the increasing complexity of drugs, the need for detailed molecular analysis, and stringent regulatory requirements are key drivers for the expanding NMR spectroscopy market.
Another factor driving the expansion of the Nuclear Magnetic Resonance (NMR) Spectroscopy market is the increase in clinical trial activity. For example, in May 2024,
Arvinas, Inc. and Pfizer Inc. announced updated clinical data from a Phase 1b combination cohort that evaluated vepdegestrant, an investigational oral PROteolysis TArgeting Chimera (PROTAC(R)) estrogen receptor (ER) degrader, in combination with palbociclib (IBRANCE(R)).
Thus, pharmaceutical companies rely on NMR for accurate structural elucidation, compound screening, and metabolite analysis during these phases. As more drugs undergo clinical trials, the demand for NMR spectroscopy increases to support the characterization and validation of potential drug candidates. The expected surge in demand for NMR Spectroscopy is projected to fuel the growth of the overall NMR Spectroscopy market throughout the forecast period from 2024 to 2030.
However, the lack of well-trained individuals who can effectively operate NMR devices, and the high cost of NMR may restrict the growth of the overall Nuclear Magnetic Resonance (NMR) Spectroscopy market.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Segment Analysis:
Nuclear Magnetic Resonance (NMR) Spectroscopy Market by Product Type (Instruments, Accessories), Type (Low-Field NMR Spectroscopy, High-Field NMR Spectroscopy), End-User (Academic, Pharmaceutical & Biotech Companies, Agriculture & Food, and others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the overall Nuclear Magnetic Resonance (NMR) Spectroscopy market, the Instrument category is expected to hold the largest share in the year 2023. The large market share of Instrument NMR is driven by its numerous advantages, Instrumental NMR spectroscopy offers a myriad of advantages that make it an indispensable analytical technique across various fields. Firstly, it provides non-destructive analysis, preserving the integrity of samples for subsequent experiments or further analysis. NMR yields detailed structural information that clarifies the chemical composition, configurations, and spatial arrangements of molecules in solution.
Moreover, it facilitates quantitative analysis by determining concentrations and stoichiometry accurately. Its versatility extends to a wide range of sample types, including small organic molecules, proteins, nucleic acids, polymers, and complex mixtures, and it can analyze samples in different states such as solutions, solids, and gases. Additionally, NMR spectroscopy provides insights into molecular dynamics, including conformational changes, motions, and interactions, through techniques like relaxation measurements and diffusion NMR. Modern instruments offer high sensitivity and selectivity, enabling the detection of low-concentration compounds and providing distinct signals for different nuclei within a molecule.
Furthermore, NMR spectroscopy can be adapted for imaging applications such as Magnetic Resonance Imaging (MRI), allowing non-invasive visualization of internal structures in biological systems with excellent spatial resolution. These collective advantages underscore the pivotal role of NMR spectroscopy in scientific research, and clinical applications.
As the demand for this segment grows, various novel products are launched by various players operating in the market across the world. For example, in April 2023, Nanalysis Scientific Corp announced that QUAD Systems debuted the new 400MHz High Field NMR system in collaboration with Nanalysis at the Experimental Nuclear Magnetic Resonance Conference (ENC 2023) in Pacific Grove, California.
Therefore, owing to the aforementioned advantages of the NMR devices, the market is expected to grow thereby propelling the overall market growth for Nuclear Magnetic Resonance (NMR) Spectroscopy during the forecast period from 2024 to 2030.
North America Is Expected To Dominate The Overall Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Among all the regions, North America is expected to hold the largest share of the global Nuclear Magnetic Resonance (NMR) Spectroscopy market in 2023. The NMR Spectroscopy market in North America is expected to grow significantly due to several factors. Advancements in technology, such as higher field strength magnets and enhanced software capabilities, are making NMR instruments more efficient and user-friendly. Further, strong research and development infrastructure, and strategic collaborations among the key players in the region is also driving the market growth. The region's focus on personalized medicine and biopharmaceuticals fuels demand, while its healthcare market increasingly utilizes NMR spectroscopy in clinical research and diagnostics. These combined factors are boosting the NMR spectroscopy market in North America.
Also, the region boasts a robust research and development infrastructure across academia and industry. Major pharmaceutical, biotechnology, and chemical companies, alongside leading academic institutions, heavily invest in NMR spectroscopy for crucial research in drug discovery, structural biology, and materials science.
Additionally, North America's healthcare market, characterized by significant investments in research, diagnostics, and therapeutics, increasingly utilizes NMR spectroscopy in clinical research, biomarker discovery, and diagnostic imaging, further contributing to market growth. Compliance with regulatory standards drives adoption for quality control, validation, and compliance testing, further boosting market growth.
Furthermore, recent strategic initiatives and various product launches of NMR Spectroscopy are also aiding in driving the market growth of NMR Spectroscopy in the region. For example, in April 2023, Bruker launched the Ascend Evo 400, a new standard 400 MHz NMR magnet with a liquid helium hold time of one year to reduce the cost of ownership and enhance operational convenience.
Therefore, the interplay of all the aforementioned factors, among others is expected to boost the growth of the Nuclear Magnetic Resonance (NMR) Spectroscopy market in the North America region during the forecast period from 2024 to 2030.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Key Players:
Some of the key market players operating in the Nuclear Magnetic Resonance (NMR) Spectroscopy market include Bruker, Oxford Instruments, JEOL Ltd., magritek, Thermo Fisher Scientific Inc., Anasazi Instruments, Inc., Nanalysis, Shimadzu Corporation, Quantum Design Inc., Horiba, Oxford Instruments, Spinlock, QUAD Systems, BLUEFORS, BUCHI, and others.
Recent Developmental Activities In The Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Key Takeaways From The Nuclear Magnetic Resonance (NMR) Spectroscopy Market Report Study:
Target Audience Who Can Be Benefited From This Nuclear Magnetic Resonance (NMR) Spectroscopy Market Report Study:
Frequently Asked Questions For The Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical technique used to determine the structure, dynamics, reaction state, and chemical environment of molecules. It exploits the magnetic properties of certain atomic nuclei.
The Nuclear Magnetic Resonance (NMR) Spectroscopy market is estimated to grow at a CAGR of 5.21% during the forecast period from 2024 to 2030.
The NMR Spectroscopy market is set for growth due to advancements like higher magnetic field strengths and cryogenically cooled probes, which improve sensitivity and resolution for detailed molecular studies. Automated, high-throughput systems enhance data collection efficiency, meeting the need for rapid analysis. In the pharmaceutical and biotechnology sectors, NMR spectroscopy plays a pivotal role in drug discovery and development by providing precise structural elucidation, compound screening, and metabolite analysis. The increasing importance of biologics highlights the need for sophisticated techniques like NMR. Additionally, expanding applications in metabolomics and personalized medicine for metabolite profiling and biomarker discovery further drives the market growth during the forecast period of 2024 to 2030.
Some of the key market players operating in the Nuclear Magnetic Resonance (NMR) Spectroscopy market include Bruker, Oxford Instruments, JEOL Ltd., Magritek, Thermo Fisher Scientific Inc., Anasazi Instruments, Inc., Nanalysis, Shimadzu Corporation, Quantum Design Inc., Horiba, Oxford Instruments, Spinlock, QUAD Systems, BLUEFORS, BUCHI, and others.
Among all the regions, North America is expected to hold the largest share of the global Nuclear Magnetic Resonance (NMR) Spectroscopy market in 2023. The NMR Spectroscopy market in North America is expected to grow significantly due to several factors. Advancements in technology, such as higher field strength magnets and enhanced software capabilities, are making NMR instruments more efficient and user-friendly. Further, strong research and development infrastructure, and strategic collaborations among the key players in the region is also driving the market growth. The region's focus on personalized medicine and biopharmaceuticals fuels demand, while its healthcare market increasingly utilizes NMR spectroscopy in clinical research and diagnostics. These combined factors are boosting the NMR spectroscopy market in North America.